In vivo T-cell depletion with antithymocyte globulin or alemtuzumab for unrelated donor stem cell transplantation with reduced intensity conditioning: results of a multicentre randomized phase II clinical trial (the Global study) from the GITMO

被引：0
|
作者：
Algarotti, A. [1 ]
Mico, C. [1 ]
Corradini, P. [2 ]
Falda, M. [3 ]
Alessandrino, E. P. [4 ]
Fanin, R. [5 ]
Tagliaferri, E. [6 ]
Castagna, L. [7 ]
Mordini, N. [8 ]
Sica, S. [9 ]
Santarone, S. [10 ]
Levis, A. [11 ]
Iori, A. [12 ]
Pollichieni, S. [13 ]
Sacchi, N. [13 ]
Scarano, M. [14 ]
Masciulli, A. [14 ]
Marchioli, R. [14 ]
Bacigalupo, A. [15 ]
Bosi, A. [16 ]
Rambaldi, A. [1 ]
机构：
[1] Osped Papa Giovanni XXIII, Bergamo, Italy
[2] Ist Nazl Tumori, I-20133 Milan, Italy
[3] Osped San Giovanni Battista Torino, Turin, Italy
[4] Policlin San Matteo, I-27100 Pavia, Italy
[5] AO Univ Udine, Udine, Italy
[6] Osped Maggiore Policlin, Milan, Italy
[7] Ist Clin Humanitas, Milan, Italy
[8] AO Santa Croce & Carle, Cuneo, Italy
[9] Policlin Gemelli, Rome, Italy
[10] Osped Civile, Pescara, Italy
[11] AO SS Antonio & Biagio & C Arrigo, Alessandria, Italy
[12] Univ Roma La Sapienza, Rome, Italy
[13] Osped Galliera, Genoa, Italy
[14] Ist Mario Negri Sud, Santa Maria Imbaro, Italy
[15] Osped San Martino Genova, Genoa, Italy
[16] Osped Careggi, Florence, Italy
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S60 / S61
页数：2
相关论文
共 50 条
  • [31] T-cell depletion does not necessarily compromise donor stem cell engraftment in patients receiving reduced-intensity conditioning regimens
    C Craddock
    A P Grigg
    Bone Marrow Transplantation, 2003, 31 : 1177 - 1177
  • [32] Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning:: results of a prospective multicentre study
    Martino, R
    Caballero, MD
    Canals, C
    Simón, JAP
    Solano, C
    Urbano-Ispízua, A
    Bargay, J
    Rayón, C
    Léon, A
    Sarrá, J
    Odriozola, J
    Conde, JG
    Sierra, J
    San Miguel, J
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (03) : 653 - 659
  • [33] Long-term results of allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin
    Krejci, M.
    Brychtova, Y.
    Doubek, M.
    Tomiska, M.
    Navratil, M.
    Racil, Z.
    Dvorakova, D.
    Horky, O.
    Lengerova, M.
    Pospisilova, S.
    Mayer, J.
    NEOPLASMA, 2011, 58 (05) : 406 - 414
  • [34] Outcome following haploidentical haematopoietic stem cell transplantation using ex-vivo T-cell depletion and reduced intensity conditioning in children with acute leukemia
    Turkiewicz, D.
    Ifversen, M.
    Dykes, J.
    Heilmann, C.
    Pronk, C.
    Mueller, K.
    Fischer-Nielsen, A.
    Toporski, J.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S249 - S249
  • [35] No difference between ATG and alemtuzumab when used for T-cell depletion in reduced intensity conditioned haematopoietic stem cell transplantation for MDS and AML
    Floro, L.
    Potter, V.
    Noriega, V.
    Kenyon, M.
    Marsh, J.
    Raj, K.
    De Lavallade, H.
    McLornan, D.
    Devereux, S.
    Mufti, G.
    Pagliuca, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S229 - S230
  • [36] Comparative Analysis of Sibling Donor Reduced Intensity Conditioning Regimen for High Risk AML/MDS Using Anti-Thymocyte Globulin Versus Alemtuzumab for T-Cell Depletion
    Lim, ZiYi
    Bennett, Sarah
    Ho, Aloysius Y. L.
    Kulasekararaj, Austin G.
    Gupta, Sunil
    Kenyon, Michelle
    Hayden, Janet
    Marsh, Judith C. W.
    Pagliuca, Antonio
    Mufti, Ghulam J.
    BLOOD, 2009, 114 (22) : 1305 - 1305
  • [37] ALEMTUZUMAB VS ATG FOR T-CELL DEPLETION IN SIBLING DONOR REDUCED INTENSITY HAEMATOPOIETIC STEM CELL TRANSPLANTATION (RIC HSCT) FOR THE TREATMENT OF ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROME
    Potter, V. T.
    Tindell, V. J.
    Reiff-Zall, L.
    Ho, A.
    Kenyon, M.
    Marsh, J.
    Pagliuca, A.
    Mufti, G. J.
    Lim, Z.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S289 - S289
  • [38] Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study
    Krishnan, Biju
    Else, Monica
    Tjonnfjord, Geir E.
    Cazin, Bruno
    Carney, Dennis
    Carter, John
    Ketterer, Nicolas
    Catovsky, Daniel
    Ethell, Mark
    Matutes, Estella
    Dearden, Claire E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (06) : 907 - 910
  • [39] In vivo T-cell depletion with pretransplant low-dose antithymocyte globulin is associated with reduced transplant-related mortality and improved clinical outcome in patients receiving allogeneic hematopoietic stem cell transplantation from unrelated and partially matched related donors
    Busca, Alessandro
    Locatelli, Franco
    Flonta, Simona Emilia
    Ciccone, Gianni
    Baldi, Ileana
    D'Ardia, Stefano
    Allione, Bernardino
    Falda, Michele
    AMERICAN JOURNAL OF HEMATOLOGY, 2011, 86 (02) : 214 - 217
  • [40] Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation
    Pavletic, SZ
    Carter, SL
    Kernan, NA
    Henslee-Downey, J
    Mendizabal, AM
    Papadopoulos, E
    Gingrich, R
    Casper, J
    Yanovich, S
    Weisdorf, D
    BLOOD, 2005, 106 (09) : 3308 - 3313
12345